Establishing the evidence base of interventions taking place in areas such as psychology and special education is one of the research aims of single-case designs in conjunction with the aim of improving the well-being of participants in the studies. The scientific criteria for solid evidence focus on the internal and external validity of the studies, and for both types of validity, replicating studies and integrating the results of these replications (i.e., meta-analyzing) is crucial. In the present study we deal with one of the aspects of meta-analysis, namely the weighting strategy used when computing an average effect size across studies. Several weighting strategies suggested for single-case designs are discussed and compared in the context of both simulated and real-life data. The results indicated that there are no major differences between the strategies and, thus we consider that it is important to choose weights with a sound statistical and methodological basis, while scientific parsimony is another relevant criterion. More empirical research and conceptual discussion are warranted regarding the optimal weighting strategy in single-case designs, alongside investigation of the optimal effect size measure in these types of design.
The evidence-based movement has now been salient for several years in a variety of disciplines including psychology (APA Presidential Task Force on Evidence-Based Practice, 2006), medicine (Sackett, Rosenberg, Gray, Hayness, & Richardson, 1996) , and special education . In this context, single-case designs (SCD) 1 have been considered one of the viable options for obtaining evidence that would serve as a support for interventions and practices Schlosser, 2009) . Accordingly, randomized single-case trials have been included in the new version of the classification elaborated by the Oxford Centre for
Evidence-Based Medicine regarding the methodologies providing solid evidence (Howick et al., 2011) . Thus, it is clear that one of the ways of improving methodological rigor and scientific credibility is by incorporating randomization into the design , given the importance of demonstrating causal relations (Lane & Carter, 2013) . Demonstrating causeeffect relations is central to SCD, provided that they are "experimental" in essence (Kratochwill et al., 2013; Sidman, 1960) and, apart from using random assignment of conditions to measurement times, it is also favored by replication of the behavioral change contiguous with the change in conditions (Kratochwill et al., 2013; Wolery, 2013) . On the other hand, replication is also related to generalization (Sidman, 1960) , which benefits from research synthesis and metaanalysis. In that sense, the evidence-based movement has also paid attention to the metaanalytical integration of replications or studies on the same topic (Beretvas & Chung, 2008b; Jenson, Clark, Kircher, & Kristjansson, 2007) . The quantitative integration is deemed especially useful when moderator variables are included in the meta-analyses (Burns, 2012; Wolery, 2013) .
Finally, it has been stressed that meta-analysis and the assessment of internal and external 1 We chose the term single-case designs (SCD) in order to be consistent with the labeling used in the articles recently published in this journal by, for instance, Baek and Ferron (2013) , Shadish and Sullivan (2011) , Shadish, Rindskopf, Hedges, and Sullivan (2013) , although these designs are also referred to as single-subject experimental designs (e.g., Ugille, Moeyaert, Beretvas, Ferron, & Van den Noortgate, 2012) . In any case, SCD are experimental in nature and not to be confused with case studies (Blampied, 2000) .
validity should not be considered separately (Burns, 2012) , given that the assessment of the methodological quality of a study is an essential part of the process of carrying out research syntheses (Cooper, 2010; Littell, Corcoran, & Pillai, 2008; What Works Clearinghouse, 2008) for instance using the methodological quality scale in SCD (Tate et al., 2013) or the Study DIAD (Valentine & Cooper, 2008) as more general tools.
Despite the current prominence of hierarchical linear models (Gage & Lewis, 2012; Owens & Ferron, 2012) , more research and debate is needed regarding the optimal way in which research synthesis ought to take place in the context of SCD (Lane & Carter, 2013; Maggin & Chafouleas, 2013 ). The present study represents an effort to discuss and obtain evidence regarding the metaanalysis of single-case studies; its focus is on weighting strategies rather than on the effect size measures that summarize the results. In that sense, it should be stressed that we do not advocate here for or against specific procedures for SCD data analysis. We consider that, while the debate on the optimal analytical techniques is still on-going, the methodological and statistical progress in SCDs will benefit from parallel research on the meta-analysis of SCD data. That is, it seems reasonable to try to solve the issue of how to combine the effect sizes from multiple studies, while also dealing with the question of which effect size measure is optimal, especially given that meta-analyses of SCD data are already taking place.
Study Aims
The purpose of the present study was to extend existing research on the meta-analysis of singlecase data, focusing on weighting strategies. After discussing the different weights suggested, a comparison is performed to explore whether the choice of a weighting strategy is critical. One of the weighting strategies studied is a proposal made here, based on considering baseline length and variability together.
The comparison was carried out in two different contexts. We used data with known characteristics (i.e., simulation) in order to study the influence of baseline and series length, data variability, serial dependence, and trend. Simulation has already been used to compare weighting strategies in the context of group designs (e.g., Marín-Martínez & Sánchez-Meca, 2010 ) and in SCD (e.g., van den Noortgate & Onghena, 2003a) . Additionally, we applied the weighting strategies to real data sets already meta-analyzed in a previously published study (Burns et al., 2012) .
Weighting Strategies
Weighting the individual studies' effect sizes is an inherent part of meta-analysis. When choosing a weighting strategy, two aspects need to be taken into account -their underlying rationale and their performance. Regarding the former aspect, in group designs, the variance of the effect size index is considered optimal (Hedges & Olkin, 1985; Whitlock, 2005) , given that it quantifies the precision of the summary measure and is, thus, related to the confidence that a researcher can have in the effect size value obtained. However, the choice of an effect size index is not as straightforward in SCD as it is in group designs. Moreover, the variance has not been derived for all effect size indices (see Hedges, Pustejovsky, and Shadish, 2012 , for an example of the complexities related to deriving the variance of a standardized mean difference). Finally, deriving the variance of the effect size index involves assumptions such as those mentioned in the Data analysis subsection for the indices included in this study. More discussion is necessary in the SCD context on whether the same weighting strategy should be considered optimal, although such practice has been recommended (Beretvas & Chung, 2008b) .
Other suggested weighting strategies also relate to the degree to which a summary measure is representative of the real level of behavior. On the one hand, greater data variability means that a summary measure represents all the data less well; suggested the inverse of data variability as a possible weight. On the other hand, when a summary measure is obtained from a longer series, the researcher can be more confident that the data gathered represent the actual (change in) behavior well and that the effects are not only temporary.
Accordingly, Horner and Kratochwill (2012) and mentioned the possibility of using series length as a weight, although its appropriateness is not beyond doubt Shadish, Rindskopf, & Hedges, 2008) . For instance, multiple probe designs (unlike multiple baseline designs) are specifically intended to produce fewer baseline phase measurements, when the pre-intervention level is stable or in the specific case zero frequency of the behavior to be learned (Gast & Ledford, 2010) . In the case of multiple probe designs the aim is to reduce the unethical withholding of a potentially helpful intervention.
Moreover, the intervention phase measurements are only continuous until a criterion is reached.
Thus, studies using this design structure might be (unfairly) penalized (i.e., treated as quantitatively less important) by weighting strategies based on baseline or series length.
Another possible weight related to the amount of information available is the number of participants in a study, suggested by and used, for instance, by Burns (2012) . Nonetheless, its proponents state that there is no "strong statistical justification" (p. 24) for its use. Finally, using unweighted averages has also been considered and appears to be a common practice (Schlosser, Lee, & Wendt, 2008) .
The proposal we make here is that, when considering the importance of data variability and the number of measurements available, the focus should be on the baseline, consistent with the the attention paid to it by applied researchers and methodologists. In SCD, this phase is used for gathering information on the initial situation and is necessary for establishing a criterion against which the effectiveness of a treatment is evaluated. On the one hand, longer baselines show more clearly what the pre-intervention level of behavior is and this level (including any existing trends) can be projected with a greater degree of confidence into the treatment phases and compared with the actual measurements. Baseline length is explicitly mentioned in several SCD appraisal tools (Wendt & Miller, 2012) , with a minimum of 5 measurements for a study to receive a high score in the standards elaborated by the What Works Clearinghouse team and in the methodological quality scale for SCD (Tate et al., 2013) .
On the other hand, baseline stability is critical for any further assessment of intervention effectiveness (Kazdin, 2001; Smith, 2012) , given that consistent responding is key to predicting how the behavior would continue in absence of intervention . Finally, the focus on the baseline rather than on the whole series is warranted, given that if the data series are considered as a whole, any potential effect will introduce variability, as the pre-intervention and the post-intervention measurements will not share the same level or trend. Thus, whole series variability is not an appropriate weight given that it is confounded with intervention effectiveness. Besides the justification of the weight chosen, it is relevant to explore the effect of using different weights when integrating SCD studies and this is dealt with in the remainder of the article.
A Comparison of Weighting Strategies: Simulation Study

Method
Data generation: design. The simulation study presented here is based on multiple baseline designs (MBD) for three reasons. Firstly, previous reviews (Hammond & Gast, 2010; Shadish & Sullivan, 2011; Smith, 2012) suggest that this is the SCD structure used with greatest frequency in published studies (around 50% in the former two and 69% in the latter). Secondly, in the meta-analysis carried out by Burns et al. (2012) (and re-run here) most of the studies included in the quantitative integration are MBD. Thirdly, MBD meet the replication criteria suggested by Kratochwill et al. (2013) for designs allowing solid scientific evidence to be obtained.
Subsequent quantifications are based on the idea that the comparisons should be made between adjacent phases (Gast & Spriggs, 2010; , that is, within each of the three tiers simulated and, afterwards, that averages are obtained across tiers.
Data generation: model and data features. Data were generated using Monte Carlo methods via the following model, presented by Huitema and McKean (2000) , and used previously in other SCD simulation studies (e.g., Beretvas & Chung, 2008a; Ferron & Sentovich, 2002; Ugille et al., 2012) :
The following variables are used in the model: T refers to time, taking the values 1, 2, …, n A + n B (where the latter are the phase lengths), D is a dummy variable reflecting the phase (0 for baseline and 1 for intervention) and used for modeling level change, whereas the interaction between D and T models slope change. In this model, serial dependence can be specified via the first-order autoregressive model for the error term ε t = φ 1 • ε t-1 + u t , with φ 1 being set to either 0 (independent data), .3, or .6, and u t being a normally distributed random disturbance. These autocorrelation values cover those reported by Shadish and Sullivan (2011) for 531 MBD studies reviewed: a random effects meta-analytic mean of these autocorrelations was .145, which, when corrected for bias, was equal to .320. In order to cover a greater range of possibilities, in some conditions the degree of autocorrelation was homogeneous for the whole series, whereas in others there was nonzero autocorrelation only for the baseline data. See Figure 1 for a graphical representation of the experimental conditions of the simulation study.
INSERT FIGURE 1 ABOUT HERE
Regarding the remaining simulation parameters (β 0 , β 1 , β 2 , and β 3 ), we wanted their selection to be based on the characteristics of real behavioral data rather than selecting completely arbitrary values. Therefore, we focused on the studies included in the Burns et al. (2012) (ranging up to 30 in Burns, 2005) . Based on the data in these two studies, we also chose the baseline level β 0 (set to 40 and 7, respectively), and the standard deviation of the random normal disturbance u t with zero mean (set to 7 and 3, respectively). The level change parameter β 2 was set to 26 and 11 for the percentage and the count metrics, respectively, on the basis of the effects found in the abovementioned studies. The slope change parameter β 3 was set to 1 for the 0-30 metric, approximately equal to the difference in slopes in the Burns (2005) data, whereas for the 0-100 metric it was set to 3 in order to represent roughly the ratio between the scales (100:30 ≈ 3:1). Finally, baseline trend (β 1 ) was set to 0 in the reference condition. In the conditions with change in slope, β 1 was set to 1 for the 0-30 metric,
given that in the only MBD tier of the Burns (2005) study in which there was some indication of baseline trend (for Student 2), the ordinary least squares slope coefficient was equal to 1.1;
analogously, β 1 was set to 3 for the 0-100 metric. 
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Data generation: phase lengths. Using the model presented above, ten three-tier MBD data sets (k = 10) were simulated for each iteration, and later integrated quantitatively. In previous simulation studies related to single-case meta-analysis (Owens & Ferron, 2012; Ugille et al., 2012 ) k = 10 was also one of the conditions studied. However, given that in those studies the estimation of effects was the object, k was more relevant than in the present study where weighting strategies are being compared.
The basic MBD data set, used as a reference, contained 20 measurements (n A = n B = 10) in each tier, following two pieces of evidence. On the one hand, Shadish and Sullivan (2011) reported that the median and modal data points in the SCD studies included in their review was 20. On the other hand, Smith (2012) reported a mean of 10.4 baseline data points in MBD, which is consistent with the Shadish and Sullivan (2011) data that (54.7%) of the SCDs had five or more points in the first baseline.
Each generation of ten studies and posterior meta-analytical integration was iterated 1,000 times using R (R Core Team, 2013) and thus, 1,000 weighted averages were obtained for each weighting strategy and each experimental condition (i.e., for each combination of phase lengths, type of effect, data variability, degree of serial dependence, and trend).
Data generation: additional conditions for studying the effect of data variability and phase length. In the simulation study, we wanted to explore the effect of data variability and phase lengths as potentially important factors for the weighting strategies (see Figure 1 ). In order to study how more variability or more data points affect the weighted average, it was necessary to set different effect sizes in the different studies being integrated 2 . We decided that half of the k = 10 studies should have the effect previously presented (β 2 = 11 and β 3 = 1 for the 0-30 metric, β 2 = 26 and β 3 = 3 for the 0-100 metric), whereas for the other half the effects were multiplied by the arbitrarily chosen value of 1.5 (thus β 2 = 16.5 and β 3 = 1.5 for the 0-30 metric, β 2 = 39 and β 3 = 4.5 for the 0-100 metric). The effects and their standardized versions are available in Table 1 .
In order to study the effect of data variability, we doubled the standard deviation of the random normal disturbance u t to 6 (for the 0-30 metric) and to 14 (for the 0-100 metric) for the five studies with larger effects. Thus, we expected the weighted average to decrease. It should be 2 Otherwise, it would not be possible to study the effect of these two data features. Consider the following example, with two studies being integrated and with the raw mean difference in both being equal to 11. If the first study is given weight 2 (due to twice as many data points) and the second study is given weight 1, the weighted average is still twice 11 + once 11 divided by 3, equal to 11; the same as the unweighted average. Therefore, it is necessary to have different magnitudes of effect in order explore to what extent the weighted average moves closer to the effect size of the study given greater weight.
stressed that with the simulation parameters specified in this way, the simulated data were expected to be generally within the range of possible values, for both metrics 3 . The standardized values in Table 1 are computed, on the one hand, considering the variability in the reference condition and, on the other hand, for the conditions with greater variability.
To study the effect of phase lengths, we divided by two the number of data points in the baseline (n A = 5) or in the whole MBD tier (n A = n B = 10) for the studies with larger effects, expecting once again a reduction in the weighted average. Note that the multiplication factor was the same as when studying the effect of data variability, given that the aim was to be able to compare the changes in the weighted averages as a result of the smaller-effect-size studies containing more measurements or presenting lower variability.
Data analysis: effect size measures. Our choice of effect size measures to include in the present study was based on two criteria: knowledge of the expression of the index variance (under certain assumptions) and actual use in single-case designs. Given the considerable lack of consensus on which is the most appropriate effect size measure (Burns, 2012; Kratochwill et al., 2013; Smith, 2012) , we are aware that any choice of an analytical technique can be criticized and, in the following, we explain our choice for this particular study, although we do not claim that the measures included here are always the most appropriate ones.
In the review of single-case meta-analyses performed by Beretvas and Chung (2008b) (Scruggs & Mastropieri, 2013) , apart from the agreement with visual analysis in absence of effect (Wolery, Busick, Reichow, & Barton, 2010) . The reasons for preferring the NAP are 1) it does not depend on a single extreme baseline measure; 2) in simulation studies, the NAP has also been shown to perform well in presence of autocorrelation (Manolov, Solanas, Sierra, & Evans, 2011) , in contrast with the PND (Manolov, Solanas, & Leiva, 2010) ; 3) the NAP and the PND show similar distributions of typical values according to the review by Parker, Vannest, and Davis (2011) using real behavioral data; and 4) the critical reason for selecting the NAP was the fact that the PND does not have a known sampling distribution , which makes impossible using the most widely accepted weight for group-design studies; in contrast, there is an expression for the variance of the NAP as shown below. The NAP is a measure obtained as the percentage of pairwise comparisons for which the result is an improvement after the intervention (e.g., the intervention measurement is greater than the baseline measurement when the aim is to increase behavior). It is equivalent to an indicator called Probability of superiority (Grissom, 1994) , which is related to the common language effect size (McGraw & Wong, 1992) . Grissom and Kim (2001) provided a formula to estimate the variance of the Probability of superiority, which is also applicable to the NAP: ̂2 =
(1/ + 1/ + 1/ )/12. Note that the Probability of superiority was originally intended to compare two independent samples in the same way as the Mann-Whitney's U test and, extending this logic to SCD, it would be assumed that the data are independent and also that the variances are equal. The reader should consider whether these assumptions are plausible. The NAP has been used in single-case meta-analyses (e.g., Burns et al., 2012; Petersen-Brown, Karich, & Symons, 2012) .
Second, regarding the standardized mean difference index, according to Beretvas and Chung (2008b) , the most commonly applied version 4 was the one using the standard deviation of the baseline measurements (s A ) in the denominator, which in group designs comparing a treatment mean ( B X ) and a control group mean ( A X ) would be Glass' Δ (Glass, McGaw, & Smith, 1981) .
The index is thus defined as
and its variance is given by Rosenthal (1994) as
. Note that Δ was originally used to compare two independent groups and is based on the assumption that the sampling distribution of Δ tends asymptotically to normality and, thus, this formula is only an approximation. Moreover, although it is a standardized measure of the average difference between phases, its application to SCD data does not lead to a measure comparable to the d-statistic obtained in studies based on group designs (see Hedges et al., 2012 for a more complete explanation). This is also a reason for not using Cohen's benchmarks for interpreting the index's values (Beretvas & Chung, 2008) . Once again, we stress that we do not advocate for the use of this measure for quantifying intervention effectiveness in all SCD data.
Three aspects should be considered with regards to these two effect size measures. First, the fact that the first measure is expressed as a percentage of nonoverlap and the second measure is standardized implies that they can be applied to data measured in different metrics (which is the case for both the simulated and the real data used here). Second, the expressions for the variances of these indices do not take into account the fact that single-case data may be autocorrelated and so: a) they should be used with caution when applied to real data for which it is difficult to estimate autocorrelation precisely (Huitema & McKean, 1991; Solanas, Manolov, & Sierra, 2010 ) and b) it would be interesting to explore the effect of serial dependence on the weighted averages by computing the inverse of the indices' variance as a weight.
The third noteworthy aspect is related to situations in which the data do not show stability. It has to be mention that neither the NAP nor Δ are suitable for data which present a baseline trend not related to the intervention, as pointed out by Parker, Vannest, Davis, & Sauber (2011) and Beretvas and Chung (2008) , respectively. This is why we did not apply these indices to conditions with β 1 ≠ 0. In fact, there are several methods for dealing with trend (e.g., Allison & Gorman, 1993; Manolov & Solanas, 2009; Parker, Vannest, & Davis, 2012) .
However, modeling trend is not an easy issue, given that it is necessary to consider aspects such as phase length (Van den Noortgate & Onghena, 2003b) and reasonable limits within which data can be projected (Parker, Vannest, Davis, & Sauber, 2011) . Moreover, the issue of baseline trend is probably more critical for the effect size indices than for the weighting strategies used to assign quantitative "importance" to these indices.
Another aspect related to the effect size measures and the lack of data stability, is that NAP and Δ are not specifically designed to quantify changes in slope. Therefore, a different type of summary measure was computed here for this specific situation: the difference between the standardized ordinary least squares slope coefficients estimated separately for the treatment phase and for the baseline phase (with T as predictor in both cases). This third summary measure can be defined as diff
The NAP, ∆, and β diff were computed for each generated data set. The quantifications of the ten studies (i = 1, 2, … 10) were then integrated via a weighted average, Data analysis: weighting strategies. The weighting strategies included here were the variance of the effect size indices, series length, baseline length, baseline variability, and a proposal based on both baseline length and variability. It was expected that the data variability of the whole series might be confounded with an intervention effect, given that a mean shift or a change in slope both entail greater scatter. This is why it was not included as a weight. Another possible weight not included here is the number of participants, as it is not strongly supported by its proponents and raises the question of what weight should be used when there is only one participant in the study, for instance, when an ABAB design is used or whether in MBD across behaviors or settings, the number of tiers should also be used as a weight.
It is important to distinguish between the weighting strategies that involve computing a measure of variability. On the one hand, the classical option is related to the effect size index variance (that is, the variance of its sampling distribution). In this case, the weight is the inverse of this variance, so that a greater weight is related to greater precision of the effect size estimate.
On the other hand, the variability of the data (and not of the summary measure) is considered, here focusing on the baseline phase. In this case, the weight is the inverse of the coefficient of variation of the baseline measurements. The coefficient of variation is used to eliminate the influence of the measurement units. In this way, studies with more stable data contribute more to the average effect size.
Regarding series and baseline phase lengths, the weights are n and n A , respectively, giving greater numerical importance to studies in which more measurements are available. The proposal presented here is based on both baseline length and data variability, given that the two aspects are related and should not be assessed separately: longer baselines are desirable given that they provide more information and confidence about the actual initial situation, but even shorter baselines might be sufficiently informative if the data are stable. The weight in the proposal was defined as n A + 1/CV(A), a direct function of baseline length and inverse function of the baseline data variability measured in terms of the coefficient of variation (a nondimensional measure that makes data expressed in different units comparable). The proposal is well aligned with Kratochwill et al.'s (2010) suggestion that the first step of assessing the usefulness of the singlecase data at hand for proving scientific evidence is to check whether the baseline pattern "has sufficiently consistent level and variability". Moreover, the same authors state that "[h]ighly variable data may require a longer phase to establish stability" (p. 19).
Results
The main numerical results are presented in Table 2 for the NAP and Table 2 for Δ for conditions in which level change was simulated, and in Table 3 for β diff for conditions including slope change. In the following sections the results are presented in relation to each data feature whose effect was studied via simulation.
INSERT TABLES 2, 3, AND 4 ABOUT HERE Reference condition. The reference condition included MBD data series with ten measurements in the two phases of each tier, with no autocorrelation or trend, and variability being equal for all studies. It can be seen that the weighted averages were very similar; the only difference being the Δ value observed for the weight based on baseline data variability (and thus also present in the proposal). Thus, the choice of a weighting strategy does not seem critical.
Next we explore whether specific data features have a differential influence on either of these strategies.
Effect of phase lengths. For the NAP and β diff there were practically no differences between the weighting strategies. For the NAP, there was no difference with respect to the reference condition. For Δ the pattern of results was more complex: the unweighted average was close to the index variance only when the whole large-effect-size series were shorter. However, when only the baseline phases were shorter, the results of the Δ variance as a weight were closer to those for n A . Nonetheless, whether the index variance is an optimal weight given the issues related to its derivation should be discussed. For both types of conditions studied, the values for the proposal were in the middle of the ranges observed and, thus, represent less extreme quantifications of the average effect size.
Effect of data variability. Greater data variability is related to reducing the weighted averages for all three effect size indices, although for the NAP this reduction was only slight.
The results obtained with the different weighting strategies showed considerable similarity, the only noteworthy differences were observed for Δ when using baseline variability as a weight.
Once again, the results for the proposal were less extreme than all other weighted averages.
Effect of serial dependence. The presence of a positive autocorrelation in the data had the effect of reducing the weighted averages obtained, although this was not as marked for the NAP.
In general, φ 1 = .6 leads to underestimating the effect size when it is computed via Δ or β diff , and when a larger proportion of the data is autocorrelated (i.e., both phases of a tier, both large-and small-effect-size studies), this underestimation is more pronounced. In any case, what is central to the comparison of the weighting strategies is that for all three effect size measures the results were very similar.
Effect of trend.
When an improving baseline trend is present in the data and a procedure is not specifically designed to deal with it, this data feature can affect the quantification of the effect size, as shown once again here. For the NAP and for Δ, such a trend leads to overestimating the effect size, given that the initial improvement (and its projection into the treatment phase) is not controlled for; the results for β diff differ because an already positive slope means that the change in slope after the intervention is compared to steeper (not stable) baseline data. However, given that the current work is focused on weighting strategies and not on the performance of the effect size indices, it is important to explore whether this distortion in the estimates is similar across weights or not. In the experimental conditions studied here, the similarity is notable. Once again, there were no major differences among the weighting strategies.
A Comparison of Weighting Strategies: Real Data Meta-Analysis
Characteristics of the Meta-Analysis
The meta-analysis presented here is based on the meta-analysis carried out by Burns et al.
(2012), 5 which integrated ten studies (k = 10; the articles marked with an asterisk in the reference list were those included in the meta-analysis). However, the current re-analysis is not a direct replication of the Burns et al. (2012) study, given that we did not use median NAP values, nor convert NAP to Pearson's phi. Most of the studies included in the meta-analysis used multiple baseline designs, and focused on an intervention called Incremental Rehearsal, which is used for several teaching purposes (e.g., words, mathematics) both for children with and without disabilities.
Dealing with Dependence of Outcomes
More than one outcome can be computed for most of the single-case studies included in the meta-analysis and it does not seem appropriate to treat each outcome as independent (Beretvas & Chung, 2008b ). Here we chose to average the effect sizes within a study, which is one of the options used in group-designs meta-analysis (Borenstein, Hedges, Higgins, & Rothstein, 2009 ). However, it is also possible to choose one of the several effect sizes reported per study according to a substantive criterion or at random (Lipsey & Wilson, 2001 ).
Another issue that requires consideration is how weights are computed in order to have a single weight per study accompanying the corresponding effect size measure. Borenstein et al.
(2009) discussed the possibility of calculating a variance of an average of effect sizes within a study. However, their formulae require knowing or at least assuming plausible values for the correlations between the different study outcomes. Given that we did not want to make an assumption with no basis, we chose to obtain the average of the weights for each outcome in order to have a single weight per study. This approach has been deemed a conservative solution (Borenstein et al., 2009 ).
For instance, for multiple baseline designs (e.g., Burns, 2005) or multiple probe designs (e.g., Codding, Archer, & Connell, 2010) there is one outcome for each baseline. In such cases, it has been suggested ) that an effect size should be computed for each baseline before computing the average of these baselines; Burns et al. (2012) also computed the NAP for each baseline and then aggregated them. For designs with multiple treatments (e.g., Burns, 2007) the optimal practice is not clear, but comparing each treatment with the immediately preceding baseline seems to be the logical choice . However, given that in the Burns 
Results
The effect sizes and the different weights for each of the ten studies are presented in Table 5 .
Some aspects of the results should be commented upon, before discussing the weighted averages across studies. For the Bunn, Burns, Hoffman, and Newman (2005) study, a perfectly stable baseline (i.e., a complete lack of variability) precluded computing β diff and also ∆, its variance, or the weight related to baseline variability. Additionally, given that only ten studies were 
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The values and weights in Table 5 were used to obtain the mean effect sizes for the ten studies according to each weighting strategy; the unweighted average was also computed. The results obtained following the quantitative integration of the studies are presented in Figure 2 . For both the NAP and Δ, the proposal's results were close to the unweighted average. In contrast, the NAP variance result was closer to that obtained when n A was used as a weight and the Δ variance result was more similar to the series length weight. However, the weighted average using baseline variability as a weight yielded a somewhat different result. This latter finding is especially salient for β diff , due to the influence of the Matchett and Burns (2009) study.
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Discussion
Results and Implications
The present study is, to the best of our knowledge, the first one based simultaneously on simulation and real data comparing several weighting strategies in the context of single-case designs' meta-analysis. The results obtained here are restricted to the experimental conditions studied and more extensive research and discussion are required. However, various aspects of this work will fuel further discussion and testing with published data or via simulation.
Firstly, the issue of whether weighting is necessary when an average effect size summarizing the results of several studies is obtained should be considered. On substantive grounds, it seems logical to treat an outcome of a study as numerically more important (i.e., contributing to a greater extent) when this outcome is based on a larger amount of data and/or on a clear data pattern (i.e., with less unexplained variability). On empirical grounds, based on the results presented here, there is not enough evidence that weighting yields markedly different results. An implication of these findings (which should be considered taking into account the Limitations discussed below) is that series length alone may not be a critical feature for giving more or less weight to the results. In that sense, multiple probe designs characterized by a reduced amount of measurements may not be treated as providing less evidence. However, note that the length of the phases is also considered in the expressions for approximating the variance of the indices included in this study.
Secondly, for the cases in which certain differences are observed in the weighted averages, it is important to establish the gold standard, so that a result can be judged as more or less desirable. It that sense, whether the variance of the effect size measure is that gold standard, and whether it can be derived for single-case data, considering potential serial dependence and/or a baseline trend, should be debated. Even in the context of simulation data, it is not easy to determine which results show the best match for the simulation parameters, given that the question is "what are the optimal weights?" and thus "how different from an unweighted average should a weighted average be?".
Third, we consider that the discussion on the theoretically most appropriate weight (i.e., the one that has the most solid statistical justification in the context of SCD data) can take place in parallel with empirical testing, carried out with real or simulated data. With the results presented here, the door for a substantive discussion appears to remain wide open, given that no major differences were obtained across the weighting strategies.
Fourth, some methodological implications of the results should be mentioned, taking into account the limitations discussed below. First, it might not be necessary to derive the sampling distribution of an effect-size index analytically (e.g., Hedges et al., 2012) or via simulation (e.g., Manolov & Solanas, 2012) in order to be able to obtain its variance and then use it as a weighting factor. Regarding the variance of standardized mean difference measures such as Δ, it has been claimed that the presence of serial dependence in the data makes the sampling distribution unknown and thus the formulae for the variances might not be correct (Beretvas and Chung, 2008b) , which is the one of the reasons for the current developments in the field by Hedges and colleagues (2012) .
This being said, we consider that until more evidence is available, two approaches seem to be logically and empirically supported. The first approach consists in using the weighting strategy whose underlying statistical foundations are more solid: the index variance. The work of Hedges et al. (2012) is an important step in this direction in order to have available measurements and weights appropriate for SCD, avoiding the need to make assumptions about the data so that they would fit the measures and weights used in group-design studies. Using a weight based on widely accepted statistical theory can be useful for enhancing the scientific credibility of the meta-analyses of SCD data. Nonetheless, issues such as estimating autocorrelation (so that it can be accounted for) still need to be solved, whereas future developments more closely related to the d-statistic are also expected .
The second approach consists in simplifying the weighting strategy to using either baseline length only or baseline length and variability -two widely available and relevant pieces of information. The main reason for such an option would be the lack of difference in performance (considering the limitations of the current evidence) as compared to the index variance weight.
That is, following this approach would be based on the principle of scientific parsimony (also known as Occam's razor), according to which a simpler solution might be useful until it is demonstrated to be inferior. We consider that, subject to further testing and discussion, this approach is well aligned with the requirement of being "scientifically sound yet practical" (Schlosser & Sigafoos, 2008, p. 118) . The first option would be to use only baseline phase length as a weight, given that it actually is a special case of the variance estimate presented by Hedges and colleagues (2012; equation 5): it is the case in which autocorrelation is not taken into account and the focus is put solely on the baseline phase. Regarding the assumption of no autocorrelation, it might be justifiable considering the autocorrelations reported by Shadish and Sullivan (2011) : the bias-corrected values ranged from −.010 for alternating treatments designs to .320 for MBD. The second option in the context of this parsimonious approach would be to use baseline length and the inverse of baseline data variability as weight. The rationale for such a weight would be to avoid penalizing excessively multiple probe designs in which few preintervention measurements are obtained, but they show stability. Choosing either of the two approaches can be a question of further debate.
Fifth, we would like to encourage applied researchers to publish not only their raw data in a graphical format, but also to compute the primary summary measures such as means, medians, and standard deviations for each phase, given that this information is useful for computing the weights that are necessary for meta-analysis. This would help avoid any lack of precision due to imperfect data-retrieval procedures. Meta-analysis and the identification of the conditions under which interventions are useful would also benefit from reporting the details about the participants, the settings, the procedures, and the operative definitions of the main study variables (Maggin & Chafouleas, 2013) .
Finally, researchers carrying out meta-analyses are encouraged to report both an unweighted average and a weighted average based on the strategy they consider optimal. In that way, each meta-analysis would serve as evidence based on real data regarding the impact of using weighting in meta-analytical integrations. Furthermore, each meta-analysis would contribute not only to substantive knowledge, but would also give added value in terms of the methodological discussion on how to perform research synthesis in single-case designs.
Limitations and Future Research
The results of the present study are limited to the weighting strategies and the effect size measures included. Regarding the limitations of the meta-analysis of published data, we should mention the relatively small number of studies included, and the inability to calculate variances due to flat baselines. The outlying weights due to lower baseline variability in some data sets can also be seen as a limitation. However, perfectly stable measurements can be obtained in behavioral studies (e.g., Costigan & Light, 2010) , especially when the desired effect is to eliminate the behavior studied (e.g., Friedman & Luiselli, 2008) or, regarding the baseline phase, when the initial level is zero (e.g., Drager et al., 2006) . The data meta-analyzed also reflect the fact that in some cases but not in others there might be lower baseline variability (e.g., for one of the behaviors of only one of the fours participants, studied by Dolezal, Weber, Evavold, Wylie, & McLaughlin, 2007) As limitations specific to the simulation study, it only focused on MBD and it is not clear whether the results would have been different if a variety of design structures were simulated for the data sets to be integrated; for instance, in the Burns (2012) meta-analysis not all studies followed an MBD. Although this is the most common design structure, there are other designs that can provide strong evidence on intervention effectiveness according to the criteria presented by Kratochwill and colleagues (2010) and Tate et al. (2013) , such as ABAB (used in 21% of the empirical studies according to the Hammond and Gast, 2010, review; 17% in Shadish and Sullivan, 2011, and 8% in Smith, 2012) and alternating treatments designs (used in 8% of the studies in Sullivan, 2011, review, and 10% as a combination with of MBD and ATD, in Smith's, 2012 , review alternating and simultaneous treatment designs represented 6% of the studies). Moreover, a restricted set of phase lengths was studied and the data were generated on the basis of a continuous (normal) model, as is common in single-case simulation studies; but in many cases the behavior of interest in real single-case studies is measured on a discrete ratio scale (e.g., frequency of occurrence). Additionally, more extreme conditions (e.g., greater degrees of heteroscedasticity) could have been studied, but we decided to constrain the simulation data to realistic values, obtained in the published studies. Finally, the meta-analysis of real-life data was carried out using only ten studies and thus the generalization of the findings requires further field testing.
Apart from empirical comparisons between the procedures, we consider that a more thorough discussion of which is the most appropriate weight from a conceptual perspective is required.
Additionally, more discussion is necessary on how to proceed with dependent outcomes within studies in order to obtain a single effect size per study, before carrying out any integration across studies.
to teach letter identification with a preschool-aged child. Note. SD -standard deviation (references equal to 7 and 3 for the 0-100 and 0-30 metrics respectively; greater SD equal to 14 and 6 for the 0-100 and 0-30 metrics respectively). MD -mean difference between phases. β 0 -initial (baseline) level. β 1 -general trend not related to the intervention. β 2 -change in level for the reference condition and for the condition with larger effect size. β 3 -change in slope for the reference condition and for the condition with larger effect size. Note. NAP denotes the Nonoverlap of all pairs. Var(NAP): variance of the index. CV(A): coefficient of variation for the baseline data. n -series length, n A -baseline phase length. AB: both phases of a tier in the multiple-baseline design, A -the baseline phase of the tier. Note. Delta denotes Glass' Δ. Var(Delta): variance of the index. CV(A): coefficient of variation for the baseline data. n -series length, n A -baseline phase length. AB: both phases of a tier in the multiple-baseline design, A -the baseline phase of the tier. Note. β diff denotes the difference between standardized slope coefficients. CV(A): coefficient of variation for the baseline data. n -series length, n A -baseline phase length. AB: both phases of a tier in the multiple-baseline design, A -the baseline phase of the tier. 
